Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Premarket Notification “Not Substantially Equivalent” Rates Trending Upward

This article was originally published in The Gray Sheet

Executive Summary

The rate of 510(k)s found "not substantially equivalent" has been rising over the last four fiscal years, an FDL-1Office of Device Evaluation annual report suggests
Advertisement

Related Content

FDA Focus On Quicker PMA Reviews Gets Results; Review Quality Studied
FDA Focus On Quicker PMA Reviews Gets Results; Review Quality Studied
Regulatory News In Brief
Regulatory News In Brief
Approvals For Long-Pending PMAs Drive Up Average Approval Times In 2004
MDUFMA First Action: FDA Sets Review Milestones For Submissions
Higher Quality Applications Anticipated Under MDUFMA, CDRH Staffer Says
Higher Quality Applications Anticipated Under MDUFMA, CDRH Staffer Says
Advertisement
UsernamePublicRestriction

Register

MT021779

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel